{"entity":{"type":"insider","cik":"0001584348","url":"/insider/0001584348","json_url":"/insider/0001584348.json","name":"Barnes Alane P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":15,"first":"2014-03-07","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Barnes Alane P","source":"filing","n_filings":15,"first_seen":"2014-03-07","last_seen":"2026-05-15"}],"transactions":[{"id":6189987,"accession":"0000882796-26-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-26-000021","line_url":"/filing/0000882796-26-000021#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62500.0,"shares_display":"62,500","price_per_share":9.54,"price_display":"9.54","price_state":"stated","total_value":596250.0,"total_display":"596,250.00","total_whole":"596,250","shares_owned_after":400703.0,"shares_owned_after_display":"400,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-15","scope":"insider"},{"id":6163826,"accession":"0000882796-26-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-26-000015","line_url":"/filing/0000882796-26-000015#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":9.15,"price_display":"9.15","price_state":"stated","total_value":1372500.0,"total_display":"1,372,500.00","total_whole":"1,372,500","shares_owned_after":400703.0,"shares_owned_after_display":"400,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider"},{"id":5189238,"accession":"0000882796-25-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-25-000043","line_url":"/filing/0000882796-25-000043#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21773.0,"shares_display":"21,773","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":166563.45,"total_display":"166,563.45","total_whole":"166,563","shares_owned_after":398751.0,"shares_owned_after_display":"398,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4573036,"accession":"0000882796-25-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-25-000033","line_url":"/filing/0000882796-25-000033#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21210.0,"shares_display":"21,210","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":162256.5,"total_display":"162,256.50","total_whole":"162,257","shares_owned_after":315726.0,"shares_owned_after_display":"315,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider"},{"id":4057928,"accession":"0000882796-25-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000882796-25-000027","line_url":"/filing/0000882796-25-000027#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19770.0,"shares_display":"19,770","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":151240.5,"total_display":"151,240.50","total_whole":"151,241","shares_owned_after":345476.0,"shares_owned_after_display":"345,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-03","scope":"insider"},{"id":4057926,"accession":"0000882796-25-000027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000882796-25-000027","line_url":"/filing/0000882796-25-000027#line-3","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50906.0,"shares_display":"50,906","price_per_share":7.2136,"price_display":"7.21","price_state":"stated","total_value":367215.5216,"total_display":"367,215.52","total_whole":"367,216","shares_owned_after":365246.0,"shares_owned_after_display":"365,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-03","scope":"insider"},{"id":4057925,"accession":"0000882796-25-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-25-000027","line_url":"/filing/0000882796-25-000027#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91004.0,"shares_display":"91,004","price_per_share":7.1042,"price_display":"7.10","price_state":"stated","total_value":646510.6168,"total_display":"646,510.62","total_whole":"646,511","shares_owned_after":416152.0,"shares_owned_after_display":"416,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":2240658,"accession":"0001127602-24-015367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-015367","line_url":"/filing/0001127602-24-015367#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.53,"price_display":"5.53","price_state":"stated","total_value":27650.0,"total_display":"27,650.00","total_whole":"27,650","shares_owned_after":300762.0,"shares_owned_after_display":"300,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":6748072,"accession":"0001127602-22-027858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-027858","line_url":"/filing/0001127602-22-027858#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4175.0,"shares_display":"4,175","price_per_share":10.88,"price_display":"10.88","price_state":"stated","total_value":45424.0,"total_display":"45,424.00","total_whole":"45,424","shares_owned_after":198770.0,"shares_owned_after_display":"198,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":4112611,"accession":"0001127602-21-016587","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-016587","line_url":"/filing/0001127602-21-016587#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102780.0,"shares_display":"102,780","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":1237471.2,"total_display":"1,237,471.20","total_whole":"1,237,471","shares_owned_after":110275.0,"shares_owned_after_display":"110,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":2972412,"accession":"0001127602-20-031406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031406","line_url":"/filing/0001127602-20-031406#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Senior VP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Senior VP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13741.0,"shares_display":"13,741","price_per_share":7.96,"price_display":"7.96","price_state":"stated","total_value":109378.36,"total_display":"109,378.36","total_whole":"109,378","shares_owned_after":108061.0,"shares_owned_after_display":"108,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":2149349,"accession":"0001127602-20-030837","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-030837","line_url":"/filing/0001127602-20-030837#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Senior VP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Senior VP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13741.0,"shares_display":"13,741","price_per_share":6.23,"price_display":"6.23","price_state":"stated","total_value":85606.43,"total_display":"85,606.43","total_whole":"85,606","shares_owned_after":108061.0,"shares_owned_after_display":"108,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider"},{"id":8096093,"accession":"0001127602-19-033008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033008","line_url":"/filing/0001127602-19-033008#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Senior VP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Senior VP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":29000.0,"total_display":"29,000.00","total_whole":"29,000","shares_owned_after":102061.0,"shares_owned_after_display":"102,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6626528,"accession":"0001127602-18-035081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-035081","line_url":"/filing/0001127602-18-035081#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (Senior VP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Senior VP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44290.0,"shares_display":"44,290","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":401710.3,"total_display":"401,710.30","total_whole":"401,710","shares_owned_after":77953.0,"shares_owned_after_display":"77,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-04","scope":"insider"},{"id":3365241,"accession":"0001127602-16-062585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-16-062585","line_url":"/filing/0001127602-16-062585#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (VP, General Counsel & Corp Sec)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8357.0,"shares_display":"8,357","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":35684.39,"total_display":"35,684.39","total_whole":"35,684","shares_owned_after":79377.0,"shares_owned_after_display":"79,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider"},{"id":8444607,"accession":"0001127602-15-021147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-021147","line_url":"/filing/0001127602-15-021147#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (VP, General Counsel & Corp Sec)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":68876.0,"shares_owned_after_display":"68,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-22","scope":"insider"},{"id":6819887,"accession":"0001127602-14-010710","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-14-010710","line_url":"/filing/0001127602-14-010710#line-6","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001584348","owner_name":"Barnes Alane P","owner_display_name":"Barnes Alane P","owner_url":"/insider/0001584348","role":"Officer (VP, General Counsel & Corp Sec)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40734.0,"shares_display":"40,734","price_per_share":12.63,"price_display":"12.63","price_state":"stated","total_value":514470.42,"total_display":"514,470.42","total_whole":"514,470","shares_owned_after":71622.0,"shares_owned_after_display":"71,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Officer (Chief Legal Officer)","n_filings":15,"first_seen":"2014-03-07","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001584348","retrieved_at":"2026-08-26T01:38:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}